The microenvironment in classical Hodgkin lymphoma: an actively shaped and essential tumor component.
about
The immune microenvironment in Hodgkin lymphoma: T cells, B cells, and immune checkpointsRole of the tumor microenvironment in mature B-cell lymphoid malignanciesSystematic review and meta-analysis on the prognostic value of complete remission status at FDG-PET in Hodgkin lymphoma after completion of first-line therapyVariation at 3p24.1 and 6q23.3 influences the risk of Hodgkin's lymphomaHLA dependent immune escape mechanisms in B-cell lymphomas: Implications for immune checkpoint inhibitor therapy?Advances in the pathophysiology and treatment of relapsed/refractory Hodgkin's lymphoma with an emphasis on targeted therapies and transplantation strategiesModeling HLA associations with EBV-positive and -negative Hodgkin lymphoma suggests distinct mechanisms in disease pathogenesis.Expression of Interleukin-1 and Interleukin-1 Receptors Type 1 and Type 2 in Hodgkin Lymphoma.HLA expression and HLA type associations in relation to EBV status in Hispanic Hodgkin lymphoma patients.Current role of FDG PET/CT in lymphoma.Proteomic approaches to the study of malignant lymphoma: analyses on patient samples.Primary refractory and early-relapsed Hodgkin's lymphoma: strategies for therapeutic targeting based on the tumour microenvironment.Mechanisms of Immune Tolerance in Leukemia and Lymphoma.Reed-Sternberg cells in Hodgkin's lymphoma present features of cellular senescence.Microenvironmental interactions between endothelial and lymphoma cells: a role for the canonical WNT pathway in Hodgkin lymphoma.Mechanisms underlying the association between obesity and Hodgkin lymphoma.The impact of EBV and HIV infection on the microenvironmental niche underlying Hodgkin lymphoma pathogenesis.Novel treatment concepts in Hodgkin lymphoma.Characterization of the Microenvironment of Nodular Lymphocyte Predominant Hodgkin Lymphoma.CD30 cell graphs of Hodgkin lymphoma are not scale-free--an image analysis approach.Priming of the Cells: Hypoxic Preconditioning for Stem Cell TherapyImmune regulatory effects of panobinostat in patients with Hodgkin lymphoma through modulation of serum cytokine levels and T-cell PD1 expression.On the representation of cells in bone marrow pathology by a scalar field: propagation through serial sections, co-localization and spatial interaction analysis.Interleukin-31 and thymic stromal lymphopoietin expression in plasma and lymph node from Hodgkin lymphoma patients.CD68 staining correlates with the size of residual mass but not with survival in classical Hodgkin lymphoma.Biomarkers for evaluation of treatment response in classical Hodgkin lymphoma: comparison of sGalectin-1, sCD163 and sCD30 with TARC.Acquired Natural Killer Cell Dysfunction in the Tumor Microenvironment of Classic Hodgkin Lymphoma.HLA-G peptide preferences change in transformed cells: impact on the binding motif.Targeting Immune System Alterations in Hodgkin Lymphoma.The Microenvironment in Epstein-Barr Virus-Associated Malignancies.The c-Jun and JunB transcription factors facilitate the transit of classical Hodgkin lymphoma tumour cells through GIndependent Mechanisms Lead to Genomic Instability in Hodgkin Lymphoma: Microsatellite or Chromosomal Instability
P2860
Q26745842-9F01FC7F-5F79-486F-9EA8-83526B501031Q26748775-77668AB8-99D4-4261-A2FC-73428B3A9D57Q26781731-3CDBC9EB-F732-4E21-AE64-2FFE97FAE273Q28943378-4B229C29-C14A-4DD9-86CA-89EA7C0DE301Q33632104-706AC36E-39CB-4E46-9DC3-6CE079B55F27Q33886267-3CBC9674-B1D6-4111-B8B3-DDA79D0F0D80Q35554572-17ECFC9D-0365-45D3-8BD4-1068F4F11BCDQ35788358-A309E197-65C8-4A33-8814-3561B4FA7E3FQ36320074-D1624C5A-2971-42B2-A58D-C644C7C77282Q38187365-9FBF19DB-0CFD-4587-890B-8050E31A342DQ38287712-89451FF3-3EAD-49AC-B9AD-8FD13F2EEF08Q38466376-016FB767-B827-4ABA-9D09-F4357FB2306EQ38683034-9DC5F4C7-7154-4BAA-83E9-2BA71744EBA8Q38731959-13231454-C05E-47EB-9501-6602D1DCF776Q38751343-65B0A017-968D-4BC4-A209-868ECAA4AC39Q38910560-0995D281-E46E-4B1F-ACEB-E8F793C181C7Q38983067-311DB1E0-2967-4AA7-855F-0822D7EC3D9FQ39043082-DE7BA501-025F-4E70-B376-C896B717FFFFQ39937262-84939EB2-E91F-49CB-9CB7-FC9ACE2D592AQ40312648-8F7693D5-528E-4245-BCD4-BFEFD7DB31B9Q42267329-75279AB4-11E9-4B40-85CC-64C51975AF81Q42974499-6A28517C-9E62-4939-BB3A-B2C449E87201Q43045608-9370B1CA-3712-4069-8EC6-E5E48D8C81AAQ44792403-2723CD7F-A560-46A4-B7F3-884FE62585D7Q47437693-512A2FA9-0C15-4EC0-B0BA-D121B8B24C20Q51526266-E86EA48F-3033-4826-BEFB-4295A19726D7Q52680552-4C626F9B-6673-4C75-94C2-5E2D669EA66BQ53076346-EE58CCB3-BF7D-47F9-8206-8936DDAF7140Q53123844-BB64FACB-E733-4BCD-8B9F-69405948893BQ54236409-4A1DD507-1513-447A-A026-C202382E3EB1Q58099160-DAEAB7A0-DB7C-40FC-9B5D-DE0BDA9284A4Q58895253-F0C53E24-6435-42D9-AD7A-B3BA2E6409D9
P2860
The microenvironment in classical Hodgkin lymphoma: an actively shaped and essential tumor component.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The microenvironment in classi ...... and essential tumor component.
@en
type
label
The microenvironment in classi ...... and essential tumor component.
@en
prefLabel
The microenvironment in classi ...... and essential tumor component.
@en
P2093
P1476
The microenvironment in classi ...... and essential tumor component
@en
P2093
Ahmad Sattarzadeh
Arjan Diepstra
Lydia Visser
P356
10.1016/J.SEMCANCER.2013.07.002
P577
2013-07-15T00:00:00Z